DNA damage check points prevent leukemic transformation in myelodysplastic syndrome [4]

Leukemia

Volumn 21, Issue 10, 2007, Pages 2195-2198

  Horibe, S ^a   Takagi, M ^a,b   Unno, J ^a   Nagasawa, M ^a   Morio, T ^a   Arai, A ^a   Miura, O ^a   Ohta, M ^c   Kitagawa, M ^a   Mizutani, S ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b International University of Health and Welfare Mita Hospital   (Japan)

^c Tokyo Metropolitan Institute of Gerontology   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; ATR PROTEIN; CHECKPOINT KINASE 2; DNA; HISTONE H2AX; PROTEIN P53; SERINE; THREONINE;

APOPTOSIS; AUTOPHOSPHORYLATION; CELL AGING; CELL CYCLE ARREST; CONTROLLED STUDY; DNA DAMAGE; DNA REPLICATION; DNA STRAND BREAKAGE; FLUORESCENCE IN SITU HYBRIDIZATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; LEUKEMIA; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; MUTATIONAL ANALYSIS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN FUNCTION; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; WESTERN BLOTTING;

EID: 34548757363     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404748     Document Type: Letter

References (8)

1. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K et al. DNA damage response as a candidate anti-cancer barrier in early human, tumorigenesis. Nature 2005; 434: 864-870.
2. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos; P, Kotsinas A, Liloglou T et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005; 434: 907-913.
3. List AF, Vardiman J, Issa JP, DeWitte TM. Myelodysplastic syndromes. Hematol Am Soc Hematol Educ Program 2004, 297-317.
4. Yamamoto K, Abe S, Nakagawa Y, Suzuki K, Hasegawa M, Inoue M et al. Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemia. Leuk Res 2004; 28: 1203-1211.
5. Sugimoto K, Hirano N, Toyoshima H, Chiba S, Mano H, Takaku F et al. Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. Blood 1993; 81: 3022-3026.
6. Kitagawa M, Yoshida S, Kuwata T, Tanizawa T, Kamiyama R. p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia. Am J Pathol 1994; 145: 338-344.
7. Dash A, Gilliland DG. Molecular genetics of acute myeloid leukaemia. Best Pract Res Clin Haematol 2001; 14: 49-64.
8. Nakada S, Katsuki Y, Imoto I, Yokoyama T, Nagasawa M, Inazawa J et al. Early G2/M checkpoint failure as a molecular mechanism underlying etoposide-induced chromosomal aberrations. J Clin Invest 2006; 116: 80-89.